NCT01841944

Omega-3 Fatty Acids in Elderly Patients With Acute Myocardial Infarction

Giving Omega-3 Fatty Acids to Elderly Patients Diagnosed With Acute Myocardial Infarction to Investigate the Effect on Cardiovascular Morbidity and Mortality

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 1,027 (actual)
• Sponsor: Oslo University Hospital · Academic / Other
• Sex: All
• Age: 70 Years – 82 Years
• Healthy volunteers: Not accepted

Summary

The aim of the present study is to investigate the possible effects of supplementation with 1.8 g/day of n-3 polyunsaturated fatty acids on cardiovascular morbidity and mortality during a follow-up period of 2 years in an elderly population after having experienced an acute myocardial infarction. The hypothesis is that this supplementation on top of modern therapy will reduce the combined cardiovascular end-point of death, non-fatal myocardial infarction, stroke, revascularizations or hospitalization for new or worsened heart failure with at least 30%.

Conditions

• Myocardial Infarction
• Heart Failure
• Myocardial Revascularization
• Atrial Fibrillation

Interventions

Type	Name	Description
DRUG	Pikasol	Pikasol®, 3 capsules (1.8 g EPA+DHA)/day
OTHER	Corn oil	Corn oil (56% linoleic acid, 32% oleic acid, 10% palmitic acid), unchanged and according to the manufacturer

Timeline

• Start date: 2012-11-01
• Primary completion: 2020-06-26
• Completion: 2020-06-26
• First posted: 2013-04-29
• Last updated: 2020-08-19

Locations

4 sites across 1 country: Norway